What's New/
Latest news
- All
- Advocacy
- Experiences
- Guest Blog
- Information
- Research
- Reviews
- All
- Advocacy
- Experiences
- Guest Blog
- Information
- Research
- Reviews
Advocacy Pharmac responds to our erenumab funding feedback
Pharmac responds to our feedback we submitted in April following PTAC’s recommendation that erenumab be ...
Read More
InformationResearch Treatment of migraine in the emergency department
An evidence-based, medically reviewed treatment plan for people with migraine who visit the emergency department ...
Read More
Advocacy New report highlights medication underfunding in NZ
What a new report about funding of cancer medicines tells us about the broader chronic ...
Read More
AdvocacyInformation Unjustified dismissal for severe migraine – lessons for NZ
What a worker’s experience of unjustified dismissal tells us about the management of migraine in ...
Read More
Advocacy Pharmac declines application for wider range of triptans
After nearly 10 years, Pharmac finally published its decision for funding a wider range of ...
Read More
Advocacy Feedback to Pharmac on consideration of erenumab (Aimovig)
Migraine Foundation Aotearoa New Zealand has submitted feedback to Pharmac and PTAC following its consideration ...
Read More
Experiences Raising awareness of migraine on ‘The Medicine Gap’
In December 2021, a few months prior to launching Migraine Foundation Aotearoa New Zealand, one ...
Read More
Experiences Highlighting the impact of migraine in New Zealand
One of our co-founders, Dr Fiona Imlach, penned a compelling piece for The Medicine Gap ...
Read More
